Researchers have uncovered the molecular mechanisms behind cognitive deficits and brain fog associated with chemotherapy, and identified a current FDA-approved drug for multiple sclerosis that can help reduce chemotherapy-induced cognitive impairments.
A new study reports the chemotherapy drug cisplatin can kill sensory cells in the inner ear and cause permanent hearing loss.
A new synthetic peptide has the potential to deliver medications through the blood brain barrier.
Researchers confirm the mental fogginess produced as a result of taking the cancer drug tamoxifen, is real. They have also discovered an existing drug compound which appears to counteract the effects of this medication.